Sakar Healthcare Limited — Others, 08-02-2025: Statement of deviation(s) or variation(s) under Reg. 32

Sakar Healthcare Limited has announced a board meeting to discuss the statement of deviation and variation regarding the utilization of funds raised through a preferential issue, specifically the conversion of warrants into equity. A total of ₹5.76 crore was raised, with no deviations reported in fund allocation for the quarter ending December 31, 2024. Notably, ₹1.45 crore has been utilized for repaying borrowings from the State Bank of India, while ₹3.90 crore remains unspent for capital expenditure within the oncology unit. This clarity on fund usage may enhance investor confidence, indicating prudent financial management and alignment with strategic goals.